Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort

  1. Sara E. Young, MD12,
  2. Arch G. Mainous III, PHD1 and
  3. Mark Carnemolla, BS1
  1. 1Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina
  2. 2Department of Family Medicine, Medical College of Georgia, Augusta, Georgia
  1. Address correspondence and reprint requests to Sara E. Young, MD, Department of Family Medicine, Medical College of Georgia, HB-3032, Augusta, GA 30912-3500. E-mail: sayoung{at}mcg.edu
Diabetes Care 2006 Dec; 29(12): 2688-2693. https://doi.org/10.2337/dc06-0915
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1—

    Characteristics of participants in the ARIC study who did not have diabetes, dementia, or stroke at baseline

    CharacteristicsnPercent
    Demographics
        Age (years)7,14853.7 (mean)
        Sex
            Male3,17344.39
            Female3,97555.61
        Race
            White5,72980.15
            Nonwhite1,41919.85
        Marital status
            Married5,81981.41
            Divorced5728.00
            Widowed4496.28
            Separated1742.43
            Never married1341.87
        Education level
            Basic education (0–11 years)1,18416.58
            Intermediate education (12–16 years)3,05742.80
            Advanced education (17–21 years)2,90240.63
    Diseases and expenses
        Hypertension2,87840.26
        No hypertension4,27059.74
        Hyperlipidemia3,81153.32
        No hyperlipidemia3,33746.68
        Depression score7,1472.18 (mean)
        Cigarette smoking status
            Never smoked3,22845.18
            Former smoker2,42433.93
            Current smoker19320.90
        Alcohol use status
            No alcohol use4,24359.36
            Alcohol use2,89440.49
        Measures of insulin resistance
            Baseline fasting insulin >12.2 mU/l1,90826.69
            Baseline fasting insulin <12.2 mU/l5,24073.30
            Baseline HOMA >2.62,60036.37
            Baseline HOMA <2.64,54863.63
  • Table 2—

    Mean baseline cognitive test scores and mean cognitive test change scores compared between those with and without hyperinsulinemia at baseline

    With hyperinsulinemiaWithout hyperinsulinemiaP value
    Fasting insulin (cutoff 75th percentile)
        Baseline DWR6.58 ± 1.426.83 ± 1.42<0.0001*
        DWR change score−0.254 ± 1.53−0.129 ± 1.540.0074*
        Baseline DSS43.0 ± 13.747.9 ± 13.1<0.0001*
        DSS change score−2.74 ± 7.30−2.51 ± 6.850.2954
        Baseline WF32.5 ± 12.335.1 ± 12.1<0.0001*
        WF change score−1.19 ± 7.86−0.532 ± 7.920.0064*
    Fasting insulin (cutoff 12.2 mU/l)
        Baseline DWR6.59 ± 1.406.85 ± 1.43<0.0001*
        DWR change score−0.205 ± 1.57−0.134 ± 1.550.0906
        Baseline DSS43.7 ± 13.748.1 ± 13.1<0.0001*
        DSS change score−2.66 ± 7.14−2.51 ± 6.860.4348
        Baseline WF32.7 ± 12.235.3 ± 12.1<0.0001*
        WF change score−1.035 ± 7.83−0.520 ± 7.940.0164*
    HOMA (cutoff 75th percentile)
        Baseline DWR6.56 ± 1.416.82 ± 1.43<0.0001*
        DWR change score−0.277 ± 1.52−0.128 ± 1.540.0025*
        Baseline DSS42.8 ± 13.847.8 ± 13.2<0.0001*
        DSS change score−2.74 ± 7.26−2.51 ± 6.870.3152
        Baseline WF32.3 ± 12.435.0 ± 12.1<0.0001*
        WF change score−1.08 ± 7.84−0.570 ± 7.930.0423*
    HOMA (cutoff 2.6)
        Baseline DWR6.64 ± 1.416.86 ± 1.43<0.0001*
        DWR change score−0.211 ± 1.54−0.120 ± 1.540.0171*
        Baseline DSS44.4 ± 13.748.4 ± 13.0<0.0001*
        DSS change score−2.57 ± 7.00−2.54 ± 6.910.8335
        Baseline WF33.1 ± 12.135.5 ± 12.2<0.0001*
        WF change score−0.88 ± 7.84−0.53 ± 7.960.0799
    • Data are means ± SD.

    • *

      ↵* Significant P values of t test.

  • Table 3—

    Linear regression models for cognitive test scores and cognitive test change scores with hyperinsulinemia variables

    β Coefficient of hyperinsulinemia variableP value
    Baseline DWR
        Fasting insulin (cutoff 75th percentile)−0.06870.0962
        Fasting insulin (cutoff 12.2 mU/l)−0.07790.0351*
        HOMA (cutoff 75th percentile)−0.06770.1154
        HOMA (cutoff 2.6)−0.03150.3583
    DWR change scores
        Fasting insulin (cutoff 75th percentile)−0.09290.0527
        Fasting insulin (cutoff 12.2 mU/l)−0.03350.4351
        HOMA (cutoff 75th percentile)−0.11350.0245*
        HOMA (cutoff 2.6)−0.05630.1604
    Baseline DSS
        Fasting insulin (cutoff 75th percentile)−0.76650.0092*
        Fasting insulin (cutoff 12.2 mU/l)−0.45980.0834
        HOMA (cutoff 75th percentile)−0.70090.0218*
        HOMA (cutoff 2.6)−0.34050.1634
    DSS change scores
        Fasting insulin (cutoff 75th percentile)−0.40390.0727
        Fasting insulin (cutoff 12.2 mU/l)−0.29310.1370
        HOMA (cutoff 75th percentile)−0.37530.1119
        HOMA (cutoff 2.6)−0.11400.5262
    Baseline WF
        Fasting insulin (cutoff 75th percentile)−0.66180.0447*
        Fasting insulin (cutoff 12.2 mU/l)−0.70980.0161*
        HOMA (cutoff 75th percentile)−0.68670.0471*
        HOMA (cutoff 2.6)−0.69180.0115*
    WF change scores
        Fasting insulin (cutoff 75th percentile)−0.56340.0226*
        Fasting insulin (cutoff 12.2 mU/l)−0.41050.0626
        HOMA (cutoff 75th percentile)−0.39520.1256
        HOMA (cutoff 2.6)−0.22960.2617
    • Reference levels being those without hyperinsulinemia at baseline. All regressions adjusted for age, sex, race, marital status, education level, smoking status, alcohol use, depression score, history of hypertension, and history of hyperlipidemia.

    • *

      ↵* Significant P values of Wald F test for hyperinsulinemia variables.

PreviousNext
Back to top
Diabetes Care: 29 (12)

In this Issue

December 2006, 29(12)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
Citation Tools
Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Sara E. Young, Arch G. Mainous, Mark Carnemolla
Diabetes Care Dec 2006, 29 (12) 2688-2693; DOI: 10.2337/dc06-0915

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Sara E. Young, Arch G. Mainous, Mark Carnemolla
Diabetes Care Dec 2006, 29 (12) 2688-2693; DOI: 10.2337/dc06-0915
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS—
    • RESULTS—
    • CONCLUSIONS—
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Prospective Study of Neuropathic Symptoms Preceding Clinically Diagnosed Diabetic Polyneuropathy: ADDITION-Denmark
  • Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes
  • Impaired Awareness of Hypoglycemia Disrupts Blood Flow to Brain Regions Involved in Arousal and Decision Making in Type 1 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • BMJ Open - Diabetes Research & Care
  • Standards of Medical Care in Diabetes
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2019 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.